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Abstract: A simultaneous quantitative profiling method for polyamines and steroids using liquid
chromatography–tandem mass spectrometry was developed and validated. We applied this method
to human serum samples to simultaneously evaluate polyamine and steroid levels. Chemical deriva-
tization was performed using isobutyl chloroformate to increase the sensitivity of polyamines. The
method was validated, and the matrix effects were in the range of 78.7–126.3% and recoveries were
in the range of 87.8–123.6%. Moreover, the intra-day accuracy and precision were in the ranges of
86.5–116.2% and 0.6–21.8%, respectively, whereas the inter-day accuracy and precision were in the
ranges of 82.0–119.3% and 0.3–20.2%, respectively. The linearity was greater than 0.99. The validated
method was used to investigate the differences in polyamine and steroid levels between treated
breast cancer patients and normal controls. In our results, N-acetyl putrescine, N-acetyl spermidine,
cadaverine, 1,3-diaminopropane, and epitestosterone were significantly higher in the breast cancer
patient group. Through receiver operating characteristic curve analysis, all metabolites that were
significantly increased in patient groups with areas under the curve >0.8 were shown. This mass
spectrometry-based quantitative profiling method, used for the investigation of breast cancer, is also
applicable to androgen-dependent diseases and polyamine-related diseases.
Keywords: polyamine; steroid; breast cancer; liquid chromatography–tandem mass spectrome-
try; serum
1. Introduction
Breast cancer is a common hormone-related cancer, which includes estrogen receptor-
positive and progesterone receptor-positive disease. According to statistics from 2017, it is
the fifth most common type of cancer in Korea and ranks fifth in cancer-related mortality.
In addition, breast cancer ranks first among women as a cause of death from cancer [1].
Although the incidence of most cancers in Korean women has been declining since 2007,
breast cancer continues to increase, with the highest incidence among other cancer types.
Despite an increasing understanding of the molecular etiology of breast cancer over the
past 20 years, there remains a lack of reliable biomarkers to monitor treatment efficacy
associated with the disease. Currently, treatment of breast cancer commonly involves
surgery, chemotherapy, radiotherapy, and hormone therapy [2]. However, it is important
to confirm the effect of breast cancer treatment with a simple experimental method.
Polyamines are aliphatic amines composed of straight chains of carbon atoms. Amines
have several biological implications, particularly polyamines, which mainly act as prolifer-
ation factors in cells. Cancer cells are highly proliferative; therefore, polyamines are one
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of the most important biomarkers in cancer research. The increase in polyamine concen-
trations in urine samples from patients with malignant cancer was first reported by D. H.
Russell in 1971 [3]. Since then, polyamines have been analyzed in various biological fluids
to investigate their potential as markers for the early diagnosis of cancer, evaluation of
progression, and prediction of disease recurrence. It can also be seen that the number of
polyamines is distributed differently depending on the type of lung and liver cancer [4].
In breast cancer patients, it has been reported that acetylated polyamines are present at a
much higher concentration compared to that in normal human breast tissue [5,6]. Moreover,
altered polyamines can be useful markers for the evaluation of breast cancer treatment
efficacy [7].
It has been suggested that hormones such as progesterone, estrogens, and androgens
are implicated in the development and/or growth of normal and neoplastic mammary
tissue. Androgens, which play an important role in the development of prostate cancer,
have also been shown to be associated with breast cancer, attracting academic attention.
This is because the growth of estrogen receptor-positive breast cancer is decreased after
blocking the androgen receptor [8]. In addition, androgens have been proposed to control
tumor growth rates [9]. Free testosterone, an androgen, might play an important role in the
development of breast cancer in women [10]. One study found that young women with
high levels of a male hormone, like androgens, have a higher risk of developing breast
cancer [11]. Progesterone, a female hormone, is also associated with breast cancer. In
particular, progesterone receptors in breast cancer cells interact with estrogen receptors
to change their mode of action and delay tumor growth [12]. This study suggests that an
overall evaluation of polyamines and steroids will provide information on breast cancer
treatment. Therefore, profiling the combined metabolism of polyamines and steroids is
required in breast cancer patients.
Metabolic approaches can monitor an individual’s status and help detect potential can-
cer biomarkers [13]. Gas chromatography–mass spectrometry and liquid chromatography–
mass spectrometry (LC-MS) are used for quantitative metabolic profiling, as mass spec-
trometry delivers high sensitivity and is capable of characterizing complex biological
samples [14,15]. In particular, in the case of cancer patients, since normal cells are mutated,
not only free polyamines but also acetylated polyamines must be analyzed in relation
to intracellular metabolic pathways. However, while analyzing acetylated polyamines
using gas chromatography–mass spectrometry, additional active hydrogen must be re-
moved, which requires additional derivatization [16]. One disadvantage of this is that
the experiment time is increased due to the use of two or more derivatizations to remove
active hydrogen sites. This process makes it less suitable for the analysis of acetylated
polyamines. In addition, more specific and sensitive results can be obtained when using
liquid chromatography–tandem mass spectrometry (LC-MS/MS) than LC-MS, which can
be carried out using one derivatization, and thus, we conducted an experiment using the
LC-MS/MS condition.
Therefore, in this study, an analytical method was validated for the simultaneous
quantitative profiling of serum polyamines and steroids. To the best of our knowledge,
this study is the first to simultaneously analyze polyamines and steroids in human serum
samples from breast cancer patients. The developed and validated method was applied to
analyze the serum concentrations of nine polyamines and eight steroids in patients with
breast cancer after treatment and in normal female subjects using LC-MS/MS system.
2. Results and Discussion
2.1. Sample Preparation and Optimization
Polyamines have a positive charge at physiological pH [17] due to amino groups in
their molecular structure; therefore, they easily bind with other substances. However,
they are low-molecular weight molecules that rapidly elute from the chromatogram and
therefore hinder accurate analysis. To solve this problem, we used an amine-carbamylated
derivatization agent, isobutyl chloroformate. Reaction with a derivatization reagent pri-
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oritizes the binding of polyamines to other substances, and, therefore, it is possible to
selectively extract polyamines.
Nine polyamines that were detected in the biological sample were subjected to an
amine-carbamylated derivatization reaction. After polyamine derivatization, deproto-
nation was difficult because the amine and carbamoyl groups formed a stable bond. In
addition, acetyl polyamine was substituted with nitrogen to which no acetyl group was
attached. As a result, one carbamoyl group was substituted in N-acetyl putrescine (N-PUT)
and N-acetyl cadaverine (N-CAD), two carbamoyl groups in N-acetyl spermidine (N-SPD),
and three carbamoyl groups in N-acetyl spermine (N-SPM).
The carbamylation procedure that has been routinely used in our laboratory for
polyamine analysis [18] had to be optimized. Serum samples were precipitated by reactions
at high temperature (60 ◦C) for 20 min, derivatized using isobutyl chloroformate, and
extracted using the liquid–liquid extraction (LLE) method with diethyl ether. Derivatization
conditions were optimized to improve analyte sensitivity. Optimum conditions were
selected by comparing the peak areas. A reaction time of 15 min (Figure 1A) and a reaction
temperature of 35 ◦C were selected (Figure 1B). The LLE method was used to clean the
sample and minimize interference. Three different eluents, diethyl ether, ethyl acetate,
and methyl tert-butyl ether (MTBE), were tested to enhance the extraction efficacy. The
extraction efficiencies of polyamines were relatively higher in MTBE; however, those of
cadaverine (CAD), PUT, and 1,3-diaminopropane (DAP) were outside the acceptable range.
The extraction efficiencies of all analytes were acceptable when diethyl ether was used
(Figure 1C). This optimization condition was the same as that in our previous experimental
conditions [18].
2.2. Liquid Chromatography–Tandem Mass Spectrometry
After the derivatization reaction, the analyte in the chromatogram can be effectively
separated and analyzed simultaneously (Figure 2). In addition, when isobutyl chlorofor-
mate is used, the reaction in the aqueous solution is easy and exhibits high efficiency. This
reaction can occur even at room temperature (20 to 25 ◦C) or with a little warming, with
the completion of the derivatization reaction occurring in a short time (5 to 15 min).
All polyamines and steroids produced protonated precursor ions [M + H]+ in the
positive ion mode. All polyamines were derivatized with isobutyl chloroformate, whereas
the steroids were not derivatized. Therefore, all steroids were detected in the free form,
and steroid analysis revealed good intensity even without derivatization. All polyamines
showed the [M + H − OCH2C3H7]+ ion as the base peak for quantitation (Figure 3). All
steroids showed the [M + H − H2O]+ ion as the base peak of a fragment of high intensity
for quantitation. In principle, LC-MS/MS using a stable internal standard (IS) is an optimal
method for quantitative analysis. In particular, among our analytes, epimer-type substances
(epitestosterone, testosterone, 17α-hydroxyprogesterone, and 11β-hydroxyprogesterone)
might show false positives. However, we tried to separate the substances in the form of
epimers as much as possible by adjusting the retention time, and there was a difference of
approximately 0.6–1 min. Using the present method with aqueous extracts of serum, we
achieved excellent separation of nine polyamines and eight steroids with no significantly
interfering background peaks.
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Figure 1. Comparison of the optimization procedures. (A) Isobutyl chloroformate derivatization 
under varying conditions including reaction time, (B) isobutyl chloroformate derivatization under 
varying reaction temperatures, and (C) extraction of liquid–liquid extraction solvents (N-PUT: N-
acetyl putrescine; CAD: cadaverine; N-SPM: N-acetyl spermine; PUT: putrescine; SPD: spermi-
dine; DAP: 1,3-diaminopropane; N-SPD: N-acetyl spermidine; N-CAD: N-acetyl cadaverine; SPM: 
spermine). The peak area ratios were expressed by dividing (A) 15 min and (B) 35 °C as standard 


















































































Figure 1. Comparison of the optimization procedures. (A) Isobutyl chloroformate derivatization under varying conditions
including reaction time, (B) isobutyl chloroformate derivatization under varying reaction temperatures, and (C) extraction
of liquid–liquid extraction solvents (N-PUT: N-acetyl putrescine; CAD: cadaverine; N-SPM: N-acetyl spermine; PUT:
putrescine; SPD: spermidine; DAP: 1,3-diaminopropane; N-SPD: N-acetyl spermidine; N-CAD: N-acetyl cadaverine; SPM:
spermine). The peak area ratios were expressed by dividing (A) 15 min and (B) 35 ◦C as standard values that we used for
the conditions of this experiment.
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Figure 2. Chromatograms of nine polyamines, eight steroids, and two internal standards (IS) in the selected reaction
monitoring mode, with target standard pretreatment (500 ng/mL). N-PUT: N-acetyl putrescine; CAD: cadaverine; N-SPM:
N-acetyl spermine; PUT: putrescine; SPD: spermidine; DAP: 1,3-diaminopropane; N-SPD: N-acetyl spermidine; N-CAD:
N-acetyl cadaverine; SPM: spermine; T: testosterone; EpiT: epitestosterone; DHT: dihydrotestosterone; PREG: pregnenolone;
17α-OHP:17α-hydroxyprogesterone; 11β-OHP: 11β-hydroxyprogesterone; A: androstenedione; P4: progesterone.
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Figure 3. Fragmentation pattern of putrescine upon isobutyl chloroformate derivatization.
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performed with 10 calibration points (0.1, 1, 5, 10, 50, 100, 500, 1000, 2000, and 5000 ng/mL),
excluding 5000 ng/mL and adding 0.5 ng/mL for 17α-hydroxyprogesterone (17α-OHP),
11β-hydroxyprogesterone (11β-OHP), androstenedione (A), and progesterone (P4). The
regression equation was found to be linear over the dynamic ranges of all analytes (with
correlation coefficient, R2 > 0.99). The limit of quantification (LOQ) values were determined
for most polyamines at 1 ng/mL, except N-acetyl spermine (N-SPM; 0.1 ng/mL). In
contrast, the LOQ values were determined for testosterone (T), epitestosterone (EpiT),
dihydrotestosterone (DHT), and pregnenolone (PREG) at 1 ng/mL, and the LOQ values
were determined for 17α-OHP, 11β-OHP, A, and P4 at 0.1 ng/mL. As shown in Table 1,
we checked the matrix effect and overall recovery. Most analytes did not present any
significant matrix effect, ranging from 78.7 to 126.3%, and the recovery of analytes was
87.8–123.6%. Precision was assessed based on the coefficient of variation (% CV), and
accuracy was assessed through the relative error rate (% bias). For polyamine analysis,
the intra-day (n = 3) precision (coefficient of variation (% CV)) and accuracy (% bias) were
in the ranges of 1.6–21.2% and 86.5–116.2%, respectively, whereas the inter-day (n = 3)
precision and accuracy were in the ranges of 0.3–20.2% and 87.8–119.3%, respectively. For
steroid analysis, the intra-day (n = 3) precision (% CV) and accuracy (% bias) were in the
ranges of 0.6–21.8% and 91–114.3%, respectively, whereas the inter-day (n = 3) precision
and accuracy were in the ranges of 1.2–18.5% and 82–108.0%, respectively (Table 2).
















N-PUT 1–5000 y = 0.0008x + 0.0986 1.42−5 0.03 0.998 1 101.4 107.4
CAD 1–5000 y = 0.0001x + 0.0718 6.07−6 0.01 0.995 1 83.1 87.9
N-SPM 0.1–5000 y = 0.084x − 0.6771 1.76−4 0.34 0.998 0.1 86.8 101.8
PUT 1–5000 y = 0.001x + 0.0949 7.90−5 0.15 0.992 1 115.5 98.2
SPD 1–5000 y = 0.01x − 0.6062 1.59−3 0.31 0.999 1 126.3 90.1
DAP 1–5000 y = 0.0013x + 0.0449 5.89−5 0.11 0.996 1 89.7 101.7
N-SPD 1–5000 y = 0.0067x + 0.419 3.76−4 0.73 0.990 1 118.4 123.6
N-CAD 1–5000 y = 0.0003x + 0.13 1.26−5 0.02 0.992 1 87.5 100.7
SPM 1–5000 y = 6E-05x + 0.0088 1.79−5 0.03 0.995 1 86.4 107.8
T 1–2000 y = 0.0032x + 0.1867 7.92−5 0.15 0.996 1 106.7 89.9
EpiT 1–2000 y = 0.0045x + 0.4609 1.59−4 0.31 0.993 1 103.4 100.4
DHT 1–2000 y = 0.0019x + 0.0017 6.13−5 0.12 0.994 1 82.1 104.7
PREG 1–2000 y = 0.0003x − 0.0244 1.11−5 0.02 0.991 1 79.3 97.7
17α-OHP 0.1–2000 y = 0.0115x + 0.1561 3.94−4 0.77 0.993 0.1 84.6 87.8
11β-OHP 0.1–2000 y = 0.0049x + 0.1846 1.83−4 0.36 0.992 0.1 88.6 91.8
A 0.1–2000 y = 0.0017x + 0.038 3.38−5 0.07 0.998 0.1 78.7 101.0
P4 0.1–2000 y = 0.0062x − 0.2893 3.01−4 0.58 0.994 0.1 100.9 96.7
N-PUT: N-acetyl putrescine; CAD: cadaverine; N-SPM: N-acetyl spermine; PUT: putrescine; SPD: spermidine; DAP: 1,3-diaminopropane;
N-SPD: N-acetyl spermidine; N-CAD: N-acetyl cadaverine; SPM: spermine; T: testosterone; EpiT: epitestosterone; DHT: dihydrotestosterone;
PREG: pregnenolone; 17α-OHP: 17α-hydroxyprogesterone; 11β-OHP: 11β-hydroxyprogesterone; A: androstenedione; P4: progesterone.
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Intra-Day (n = 3) Inter-Day (n = 3)
Accuracy Precision Accuracy Precision
(%Bias) (%CV) (%Bias) (%CV)
N-PUT
10 91.2 8.1 88.1 11.3
50 96.8 5.4 96.4 13.6
500 110.4 7.0 92.9 18.5
1000 104.1 7.0 106.7 2.6
CAD
10 86.5 13.0 93.8 13.4
50 107.4 5.9 100.0 7.9
500 95.4 11.1 103.2 5.2
1000 92.1 9.2 102.5 9.8
N-SPM
1 104.0 16.9 104.6 19.2
50 88.2 15.3 101.3 0.3
500 113.6 6.2 110.5 3.1
1000 112.8 4.8 118.3 2.9
PUT
10 99.0 10.5 107.3 18.3
50 103.5 8.6 105.5 5.8
500 99.1 15.3 115.1 3.2
1000 103.4 15.4 102.0 17.0
SPD
10 105.8 16.3 96.2 19.7
50 116.2 21.2 109.6 17.5
500 93.8 18.3 92.0 6.8
1000 98.6 19.6 104.7 11.5
DAP
10 108.6 17.1 94.3 16.4
50 105.4 8.7 94.7 20.2
500 101.2 1.7 106.6 10.1
1000 103.9 6.2 93.6 6.6
N-SPD
10 108.5 1.6 106.5 18.3
50 110.6 11.5 104.8 11.5
500 104.3 6.5 105.6 13.6
1000 114.5 2.7 106.3 16.5
N-CAD
10 95.5 13.9 115.6 4.1
50 109.6 15.1 111.0 14.3
500 110.5 9.6 90.7 12.4
1000 97.5 13.5 90.3 9.5
SPM
10 91.5 14.9 92.4 0.7
50 104.2 13.3 119.3 7.8
500 104.3 10.6 87.8 6.9
1000 103.5 12.2 98.4 16.4
T
10 104.9 12.5 106.8 17.6
50 94.8 14.0 106.1 11.2
500 104.0 2.4 94.6 2.5
1000 100.7 9.0 100.5 8.1
EpiT
10 100.9 7.0 101.7 5.9
50 106.8 9.0 102.1 6.4
500 108.6 10.0 104.0 4.3
1000 105.6 6.9 99.9 12.3
DHT
10 106.6 8.7 97.7 9.5
50 114.3 6.5 90.2 11.9
500 111.5 3.9 97.6 16.0
1000 100.6 6.8 95.5 18.5
PREG
10 111.1 17.8 82.0 17.7
50 92.4 0.6 96.6 7.5
500 98.9 16.0 96.1 11.4
1000 103.7 7.4 101.7 8.6






Intra-Day (n = 3) Inter-Day (n = 3)
Accuracy Precision Accuracy Precision
(%Bias) (%CV) (%Bias) (%CV)
17α-OHP
1 101.5 17.1 107.9 8.4
50 102.2 15.4 106.8 7.9
500 109.1 13.2 100.4 3.8
1000 96.4 1.2 95.0 1.2
11β-OHP
1 98.9 3.5 99.4 13.5
50 95.0 21.8 108.0 4.7
500 109.3 6.0 92.0 7.7
1000 109.9 7.1 106.1 7.3
A
1 106.1 5.7 107.0 10.0
50 96.9 6.9 94.8 10.2
500 101.0 1.0 107.8 4.2
1000 93.3 8.5 91.2 9.0
P4
1 99.9 19.7 101.0 1.7
50 101.0 3.5 97.1 9.4
500 91.0 13.1 98.3 8.6
1000 110.8 5.3 103.0 18.1
N-PUT: N-acetyl putrescine; CAD: cadaverine; N-SPM: N-acetyl spermine; PUT: putrescine; SPD: spermidine; DAP: 1,3-diaminopropane;
N-SPD: N-acetyl spermidine; N-CAD: N-acetyl cadaverine; SPM: spermine; T: testosterone; EpiT: epitestosterone; DHT: dihydrotestosterone;
PREG: pregnenolone; 17α-OHP: 17α-hydroxyprogesterone; 11β-OHP: 11β-hydroxyprogesterone; A: androstenedione; P4: progesterone.
2.4. Application of Serum Polyamine and Steroid Profiles to Patients with Breast Cancer and
Normal Controls
In this study, we quantitatively analyzed polyamines and steroids in human serum
from treated cancer patients and normal controls. Using 200 µL aliquots of the serum
samples, we detected nine polyamines and eight steroids for which the concentrations
varied in the ranges of 0.14–632.22 ng/mL with polyamines and 0.12–62.74 ng/mL with
steroids. Large variations in both polyamine and steroid levels were observed between
patients with breast cancer after treatment and normal controls. As shown in Table 3, all
polyamines were higher in the patient groups, whereas most of the steroids were higher in
the patient groups, except 11β-OHP. Among the metabolites we analyzed, it was confirmed
that polyamines, androgen, and progesterone levels were similar to those of reference
ranges [19–22].
2.5. Receiver Operating Characteristic Curve
Receiver operating characteristic (ROC) curve analysis is generally performed to
derive potential biomarkers. The results of ROC curve analysis were based on the results
of univariate and multivariate statistical analyses that ensured the reliability of potential
biomarkers for independent validation. Through t-test analysis, N-PUT, N-SPD, DAP,
CAD, and EpiT were found to be significant markers, and the ROC curves for these five
compounds were plotted (Figure 4). The area under the curve (AUC) for the remaining
polyamines, namely N-SPD, DAP, CAD, and EpiT, was higher than 0.8, whereas the
AUC for N-PUT and EpiT was higher than 0.9; therefore, it was possible to predict the
potential markers.
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Table 3. Concentrations of nine polyamines and eight steroids in human serum samples of patients with breast cancer after
treatment and normal controls (ng/mL).
Normal Controls (n = 10) Patients (n = 10) p Value
Mean ± SD Median, Range Mean ± SD Median, Range
Polyamines
N-PUT 11.12 ± 4.34 11.09, 1.6–16.53 61.64 ± 58.88 46.57, 15.88–183.08 0.021
CAD 60.3 ± 27.33 66.35, 12.17–96.11 208.21 ± 169.71 174.62, 31.9–545.38 0.027
N-SPM 0.53 ± 0.45 0.45, 0.14–1.81 1.1 ± 1.13 0.82, 0.16–3.6 0.12
PUT 54.88 ± 70.74 16.3, 2.65–232.98 120.94 ± 170.91 38.52, 2.38–586.46 0.146
SPD 15.15 ± 20.73 4.88, 1.3–76.45 19.92 ± 22.53 13.62, 1.06–77.13 0.551
DAP 14.38 ± 6.08 14.99, 2.5–22.12 39.48 ± 21.64 36.79, 12.02–67.47 0.003
N-SPD 31.06 ± 15.91 31.05, 4.42–58.37 57.75 ± 25.66 58.35, 15.51–95.85 0.016
N-CAD 20.04 ± 16.63 16.45, 2.45–50.16 76.8 ± 84.72 39.11, 15.28–236.6 0.109
SPM 63 ± 48.54 60, 13.91–172.96 179.37 ± 207.84 76.83, 7.58–632.22 0.121
Steroids
T 4.86 ± 3.44 3.52, 1.3–10.09 8.06 ± 6.24 6.52, 1.78–18.88 0.095
EpiT 12.64 ± 5.36 10.79, 7.51–24.55 28.74 ± 13.93 24.85, 12.39–53.79 0.004
DHT 2.35 ± 1.22 1.7, 1.6–3.76 2.71 ± 1.94 2.71, 1.34–4.08 0.809
PREG 32.98 ± 11.37 31.97, 16.16–47.4 44.87 ± 15.27 44.47, 23.56–62.74 0.106
17α-OHP 1.15 ± 1.21 0.73, 0.14–3.76 1.15 ± 1.35 0.71, 0.12–4.08 0.999
11β-OHP 2.12 ± 1.7 1.9, 0.62–5.08 1.78 ± 1.47 1.42, 0.42–4.6 0.698
A 1.41 ± 1.07 1.01, 0.29–3.29 2.73 ± 2.03 2.02, 0.68–6.73 0.09
P4 1.3 ± 0.87 1.05, 0.18–3.64 1.47 ± 0.82 1.34, 0.27–3.06 0.569
N-PUT: N-acetyl putrescine; CAD: cadaverine; N-SPM: N-acetyl spermine; PUT: putrescine; SPD: spermidine; DAP: 1,3-diaminopropane;
N-SPD: N-acetyl spermidine; N-CAD: N-acetyl cadaverine; SPM: spermine; T: testosterone; EpiT: epitestosterone; DHT: dihydrotestosterone;
PREG: pregnenolone; 17α-OHP: 17α-hydroxyprogesterone; 11β-OHP: 11β-hydroxyprogesterone; A: androstenedione; P4: progesterone.
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ciated with cell proliferation [25]. In addition, N-SPD and N-SPM were not detected in 
tissues of normal humans, whereas N-SPD was reported to increase rapidly in tissues of 
breast cancer patients [6]. In particular, acetylpolyamine is an important factor in breast 
cancer research, and our results are consistent with studies that revealed a correlation be-
tween intracellular polyamine levels and alterations in histone acetylation and deacetyla-
tion in normal and cancer cells [26,27]. Most of the steroids, except 11β-OHP, were in-
creased in breast cancer patients. In particular, EpiT was significantly higher in the patient 
group. Although there are few studies on the correlation between breast cancer and EpiT, 
certain studies have reported that epitestosterone levels are five times higher in breast 
cysts [28]. 
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Aldrich (St. Louis, MO, USA), Steraloids (Newport, RI, USA), and Tokyo Chemical Indus-
try (Tokyo, Japan). The IS, d3-epitestosterone, and 1,6-diaminohexane were obtained from 
Sigma-Aldrich for calibration. For both calibration and QC, a commercially available 
blank serum sample (UTAK laboratories Inc, Valencia, CA, USA) was used. Sodium car-
bonate, sodium bicarbonate, formic acid (ACS reagent), and isobutyl chloroformate (deri-
vatization solution) were obtained from Sigma-Aldrich. All high-performance liquid 
chromatography (HPLC)-grade organic solvents, including diethyl ether, acetonitrile, and 
methanol, were acquired from Burdick and Jackson (Muskegon, MI, USA). Deionized wa-
ter (DW) was obtained using a Milli-Q purification system (Millipore, Billerica, MA, USA). 
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All polyamines were higher in treated cancer patients than in normal controls. Since
polyamines are involved in cell proliferation, polyamine levels increase in cancer patients.
The results corroborate several studies conducted in human urine [23], serum [7], and
saliva [24]. In particular, N-PUT, N-SPD, and DAP were significantly higher in patients,
which correlated with other breast cancer research [7]. DAP has been reported to be associ-
ated with cell proliferation [25]. In addition, N-SPD and N-SPM were not detected in tissues
of normal humans, whereas N-SPD was reported to increase rapidly in tissues of breast
cancer patients [6]. In particular, acetylpolyamine is an important factor in breast cancer
research, and our results are consistent with studies that revealed a correlation between
intracellular polyamine levels and alterations in histone acetylation and deacetylation in
normal and cancer cells [26,27]. Most of the steroids, except 11β-OHP, were increased in
breast cancer patients. In particular, EpiT was significantly higher in the patient group.
Although there are few studies on the correlation between breast cancer and EpiT, certain
studies have reported that epitestosterone levels are five times higher in breast cysts [28].
3. Materials and Methods
3.1. Chemicals
Reference standards for nine polyamines and steroids were obtained from Sigma-
Aldrich (St. Louis, MO, USA), Steraloids (Newport, RI, USA), and Tokyo Chemical Industry
(Tokyo, Japan). The IS, d3-epitestosterone, and 1,6-diaminohexane were obtained from
Sigma-Aldrich for calibration. For both calibration and QC, a commercially available blank
serum sample (UTAK laboratories Inc, Valencia, CA, USA) was used. Sodium carbonate,
sodium bicarbonate, formic acid (ACS reagent), and isobutyl chloroformate (derivatization
solution) were obtained from Sigma-Aldrich. All high-performance liquid chromatography
(HPLC)-grade organic solvents, including diethyl ether, acetonitrile, and methanol, were
acquired from Burdick and Jackson (Muskegon, MI, USA). Deionized water (DW) was
obtained using a Milli-Q purification system (Millipore, Billerica, MA, USA).
3.2. Preparation of Standard Solution
To prepare the reference standard stock solutions, polyamines and steroids were
dissolved in methanol at a concentration of 1000 µg/mL. Working solutions were prepared
using serial dilution with methanol at concentrations ranging from 100 µg/mL to 1 ng/mL.
Moreover, 1,6-diaminohexane (DAH), one of the ISs, was dissolved in methanol at a
concentration of 100 µg/mL. Working solutions were prepared using serial dilution with
methanol at a concentration of 1 µg/mL. Further, EpiT-d3, another IS, was dissolved
in acetonitrile at a concentration of 10 µg/mL. Working solutions were prepared using
dilution with acetonitrile at a concentration of 1 µg/mL. All standard solutions were stored
at −20 ◦C until further use.
3.3. Sample Information and Ethics Statement
Quantitative profiling of polyamines and steroids was conducted with 20 human
serum samples from treated breast cancer patients (n = 10; aged 27 to 60 years, mean 51.5)
and normal controls (n = 10; aged 27 to 59 years, mean 45.7). Serum samples were collected
at the Yonsei University College of Medicine, and informed consent was obtained from each
participant before collection. The study was approved by the institutional review board of
Yonsei University College of Medicine (IRB No. 3-2017-0097). Participants were diagnosed
with breast cancer of stage I–III and completed cancer treatment. Moreover, breast cancer
patients completed cancer treatment, including surgery, adjuvant chemotherapy, and
radiotherapy.
3.4. Sample Preparation
To remove proteins, the serum samples (200 µL) were added to 1 mL of DW at 60 ◦C
for 20 min. After heating, 50 µL of the IS (1 µg/mL of DAH and EpiT-d3) was added.
Thereafter, the pH values of the samples were adjusted to 9.0 with 1.0 M sodium carbonate
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buffer (25 µL), and the derivatization reagent (20 µL) was added. Then, the mixture was
incubated at 35 ◦C for 15 min. After cooling, the solution was extracted twice with 2 mL of
diethyl ether for 15 min along with shaking and centrifuged for 5 min at 1300× g using a
Heraeus SEPATECH Varifuge 3.0, and the organic solvent was transferred to a new test
tube. The entire organic layer was evaporated. The method followed in this study was
the same as that described by Byun et al. [18]. The residue was reconstituted with 100 µL
of MeOH, and a 5 µL aliquot was injected into the liquid chromatography–tandem mass
spectrometry system.
3.5. Liquid Chromatography–Tandem Mass Spectrometry
LC-MS/MS analysis was performed using a Shiseido nanospace SI-2 HPLC system
(OSAKA SODA, Osaka, Japan) coupled with a Thermo LTQ XL ion trap MS capable of
electrospray ionization (Thermo, San Jose, CA, USA). Chromatographic separation was
achieved using a Thermo Hypersil GOLD C18 column (150 × 2.1 mm, particle size: 3 µm)
at a flow rate of 100 µL/min. A gradient eluent (A: 0.1% formic acid in 5% acetonitrile; B:
0.1% formic acid in 95% acetonitrile) was used. The gradient elution system was controlled
as follows: 0 min, 50% B; 0–12 min, 50–95% B (hold for 5 min); 17–18 min, 95%–50% B.
The gradient was then returned to the initial condition (50% B) and held for 10 min before
running the next sample. The column and autosampler temperatures were maintained
at 35 ◦C and 4 ◦C, respectively. The use of tandem MS systems is robust and sensitive.
First, we acquired the full spectrum of the selected precursor. Moreover, we acquired the
MS spectrum using a full scan in selected reaction monitoring (SRM) mode, and we chose
the product ion value with a higher ion intensity parameter. For each analyte, the most
abundant ion product was selected as the quantitation ion in SRM mode analysis. MS was
performed under the following conditions: spray voltage = 5.0 kV; capillary temperature
= 350 ◦C; sheath gas flow rate = 20 arb, auxiliary gas flow rate = 5 arb; capillary voltage
= 32 V; tube lens voltage = 85 V; multipole 00 offset = −4.5V. All analytes were detected
in positive ion SRM mode. The analytical conditions were optimized for each analyte
(Table 4).
Table 4. Optimized MS information for polyamines and steroids.







1,3-diaminopropane DAP 275.0 201.1 22 9.3
Putrescine PUT 289.0 215.0 28 10
Spermidine SPD 446.1 372.3 35 14.6
Spermine SPM 603.0 529.2 48 17.9
1,6-diaminohexane DAH 317.0 243.0 27 12.45
Cadaverine CAD 303.0 229.0 45 11.2
N-acetyl putrescine N-PUT 231.0 157.0 28 4.8
N-acetyl spermidine N-SPD 388.0 314.2 24 7.6
N-acetyl spermine N-SPM 545.4 471.3 37 12.5
N-acetyl cadaverine N-CAD 245.0 171.1 51 5.1
Testosterone T 289.2 271.3 56 8.7
Dihydrotestosterone DHT 291.2 255.3 24 11.1
Epitestosterone EpiT 289.2 271.3 26 9.8
Epitestosterone-d3 EpiT-d3 292.2 256.4 35 9.7
Androstenedione A 287.2 269.3 48 9.7
Pregnenolone PREG 317.2 299.3 29 14.1
Progesterone P4 315.2 297.3 30 13.9
17α-Hydroxyprogesterone 17α-OHP 331.2 313.3 22 9.8
11β-Hydroxyprogesterone 11β-OHP 331.2 313.3 29 9.2
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3.6. Validation
We carried out validation according the ICH guideline on bioanalytical method vali-
dation [29]. For validating the method, QC samples were prepared in commercial blank
serum by spiking all target analytes at four different concentrations within their respective
calibration ranges. Calibration standards and QC samples were prepared by adding a
dilution of the stock analyte solution to the blank serum samples on every validation day.
Further, the ion peak area of each metabolite was normalized by dividing it by the IS (e.g.,
polyamine groups-DAH; steroid groups-EpiT-d3).
Calibration curves were plotted with concentrations ranging from 1 to 5000 ng/mL
for most polyamines (except N-SPM; range = 0.1 to 5000 ng/mL); further, T, EpiT, DHT,
and PREG were plotted from 1 to 2000 ng/mL and 17α-OHP, 11β-OHP, A, and P4 were
plotted from 0.1 to 2000 ng/mL. The linearity was evaluated using the correlation coeffi-
cient (R2) of the calibration curves. LOQ was defined as the lowest concentration with a
signal-to-noise ratio greater than 10. Recovery was assessed to determine whether analyte
compounds were lost during sample pretreatment. Overall recoveries were calculated
by comparing the peak area ratios of analytes with the IS from all pretreatment steps
versus those of only their derivatization steps. The matrix effect of urine samples due
to endogenous substances compared to a standard solution was calculated as follows:
(the ratio of spiked analyte standards and ISs in urine—the ratio of analytes and internal
standards in blank urine)/(the ratio of the corresponding standard and IS in the standard
solution) × 100 (%) [30]. Accuracy and precision were determined using QC samples at
four concentrations, 10, 50, 500, and 1000 ng/mL, for most analytes, whereas analytes
with an LOQ of 0.1 were measured at four concentrations of 1, 50, 500, and 1000 ng/mL.
Accuracy was evaluated as the percent relative error (% bias), and precision was evaluated
as the coefficient of variation (% CV). Intra-day validation was confirmed by analyzing
three replicate samples, whereas inter-day validation was confirmed by analyzing the
sample on three different days.
3.7. Statistical Testing and Data Processing
Polyamine and steroid concentrations were obtained from the calibration curves.
Polyamines and steroid levels are expressed as the mean ± standard deviation (SD). We
used Tune plus and Xcalibur for data analysis. Comparisons between normal controls and
patients with breast cancer were performed using an independent samples Student’s t-test.
For each of the measurements, the difference between groups was analyzed using a t-test
followed by Bonferroni correction. The threshold of significance was set at p < 0.05. ROC
curves to find the possible candidate biomarkers were plotted using MedCalc software
(MedCalc Software, Mariakerke, Belgium). The threshold of significant markers was set to
an AUC value of > 0.8.
4. Conclusions
In this study, a simultaneous analysis method using LC-MS/MS with isobutyl chlo-
roformate derivatization was validated for serum polyamines and steroids. Polyamines
and steroids have different functional groups; therefore, we derivatized polyamines with
isobutyl chloroformate but not steroids. Combined quantitative profiling was performed,
and sample preparation involved derivatization and an LLE step. This method was suc-
cessful and reliable with satisfactory peak separation. Thus, we applied quantitative
profiling of serum polyamines and steroids in age-matched breast cancer patients and
normal controls and observed certain significant differences. Since we conducted the
experiment with 10 pairs, it is not accurate, but through our simultaneous analysis method,
we might be able to confirm the treatment effect for breast cancer patients. In our results,
the clinical impact of several significant compounds showing clinical relevance is expected
to be confirmed by extending the number of patients in the future. Although there are
several studies on polyamines and steroids separately, our study is the first to analyze
polyamines and steroids simultaneously. This method is advantageous as it makes use
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of a small quantity of samples and reduces the analysis time. In addition, this MS-based
quantitative profiling method will be applicable to not only polyamine-related diseases,
such as cancer, but also androgen-dependent diseases, such as male pattern baldness and
benign prostatic hyperplasia.
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